MétaCan
Menu
Back to cohort
Record W1970623261 · doi:10.1158/1538-7445.am2011-2540

Abstract 2540: Evaluation of novel <i>bis</i>-amidine osmium complex as anti-proliferative agents

2011· article· en· W1970623261 on OpenAlexaff
Ajay Matta, Leroi V. DeSouza, Tai‐Chu Lau, K. W. Michael Siu

Bibliographic record

VenueCancer Research · 2011
Typearticle
Languageen
FieldMedicine
TopicMetal complexes synthesis and properties
Canadian institutionsYork University
Fundersnot available
KeywordsHeLaApoptosisCarboplatinMTT assayCell cycleCell growthAnnexinFlow cytometryChemistryCancer researchMolecular biologyCisplatinCellBiologyMedicineBiochemistryInternal medicineChemotherapy

Abstract

fetched live from OpenAlex

Abstract Introduction. Despite improvement in current treatment strategies, including surgery, chemotherapy (CT) and radiotherapy (RT), survival of cancer patients in advanced stages has not improved significantly over the last decade. Organometallic complexes of platinum (cisplatin, carboplatin and oxaliplatin) are in use as chemotherapeutic agents worldwide. However, acquired drug resistance to these platinum complexes has necessitated the search for novel strategies to overcome this limitation, which includes combination therapies and the development of novel platinum or non-platinum complexes as drugs. Methods. Anti-proliferative effects of a bis-amidine complex (Os-Sh1) was determined by measuring the inhibition of cell proliferation using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry-based cell-cycle analysis, annexin V dye binding assay and TUNEL assay in endometrial cancer (Hec1A and KLE) and cervical cancer (HeLa) cells. Results: Cell viability (MTT) assays revealed inhibition of cell proliferation on treatment with the bis-amidine osmium complex (Os-Sh1) in HEC1A, KLE and HeLa cell lines in a dose- (1μM – 50μM) and time-dependent manner (24h – 96h). Cell-cycle analysis showed increased cell death, i.e. the sub-G0 fraction, with G0/G1-arrest and reduction in the G2/M phase of cell cycle on treatment with the Os-Sh1 in these cell lines. Results of annexin V assay suggested apoptosis as the mechanisms of Os-complex induced cell death. Apoptosis was further confirmed by TUNEL assay using flow cytometry analysis. Western blot analysis showed cleavage of caspase 9, caspase 3 and poly-ADP ribose polymerase (PARP), suggesting activation of the intrinsic mitochondrial pathway of apoptosis. Interestingly, Os-Sh1 was more effective in inhibiting cell proliferation at a lower dose and shorter period of time (LD50=20 μM, 48h) in comparison to cisplatin, carboplatin and oxaliplatin in HEC1A, KLE and HeLa cell lines. Conclusions: Our in vitro data clearly demonstrated anti-proliferative effects of a novel bis-amidine osmium complex in endometrial and cervical cancer cells at a lower dose and in shorter period of time in comparison to platinum drugs. Based on these results, we hypothesize that such osmium complex has the potential as effective cytotoxic agents wherein cancer cells acquire resistance to commonly used platinum drugs. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2540. doi:10.1158/1538-7445.AM2011-2540

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.282
Threshold uncertainty score0.990

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0100.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.723
GPT teacher head0.514
Teacher spread0.209 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicMetal complexes synthesis and propertiesFrench-language works237,207